Plans surrounding PavMed’s spinoff are becoming more lucid – pun intended. Lucid Diagnostics has filed for an initial public offering (IPO). The company is seeking to raise $57.5 million according to a filing with the Securities Exchange Commission.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,